These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 16952161
1. Quantification of serotonin 5-HT1A receptors in monkey brain with [11C](R)-(-)-RWAY. Yasuno F, Zoghbi SS, McCarron JA, Hong J, Ichise M, Brown AK, Gladding RL, Bacher JD, Pike VW, Innis RB. Synapse; 2006 Dec 01; 60(7):510-20. PubMed ID: 16952161 [Abstract] [Full Text] [Related]
2. Synthesis and initial evaluation of [11C](R)-RWAY in monkey-a new, simply labeled antagonist radioligand for imaging brain 5-HT1A receptors with PET. McCarron JA, Zoghbi SS, Shetty HU, Vermeulen ES, Wikström HV, Ichise M, Yasuno F, Halldin C, Innis RB, Pike VW. Eur J Nucl Med Mol Imaging; 2007 Oct 01; 34(10):1670-82. PubMed ID: 17579853 [Abstract] [Full Text] [Related]
4. Effect of a P-glycoprotein inhibitor, Cyclosporin A, on the disposition in rodent brain and blood of the 5-HT1A receptor radioligand, [11C](R)-(-)-RWAY. Liow JS, Lu S, McCarron JA, Hong J, Musachio JL, Pike VW, Innis RB, Zoghbi SS. Synapse; 2007 Feb 01; 61(2):96-105. PubMed ID: 17117422 [Abstract] [Full Text] [Related]
5. Two C-methyl derivatives of [11C]WAY-100635--effects of an amido alpha-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey. McCarron JA, Marchais-Oberwinkler S, Pike VW, Tarkiainen J, Halldin C, Sóvagó J, Gulyas B, Wikström HV, Farde L. Mol Imaging Biol; 2005 Feb 01; 7(3):209-19. PubMed ID: 15912425 [Abstract] [Full Text] [Related]
6. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling. Osman S, Lundkvist C, Pike VW, Halldin C, McCarron JA, Swahn CG, Farde L, Ginovart N, Luthra SK, Gunn RN, Bench CJ, Sargent PA, Grasby PM. Nucl Med Biol; 1998 Apr 01; 25(3):215-23. PubMed ID: 9620626 [Abstract] [Full Text] [Related]
7. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate. Saigal N, Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. J Nucl Med; 2006 Oct 01; 47(10):1697-706. PubMed ID: 17015907 [Abstract] [Full Text] [Related]
9. Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar. la Fougère C, Böning G, Bartmann H, Wängler B, Nowak S, Just T, Wagner E, Winter P, Rominger A, Förster S, Gildehaus FJ, Rosa-Neto P, Minuzzi L, Bartenstein P, Potschka H, Cumming P. Neuroimage; 2010 Jan 15; 49(2):1406-15. PubMed ID: 19796699 [Abstract] [Full Text] [Related]
10. Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET. Osman S, Lundkvist C, Pike VW, Halldin C, McCarron JA, Swahn CG, Ginovart N, Luthra SK, Bench CJ, Grasby PM, Wikström H, Barf T, Cliffe IA, Fletcher A, Farde L. Nucl Med Biol; 1996 Jul 15; 23(5):627-34. PubMed ID: 8905828 [Abstract] [Full Text] [Related]
11. The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivo. McCarron JA, Pike VW, Halldin C, Sandell J, Sóvágó J, Gulyas B, Cselényi Z, Wikström HV, Marchais-Oberwinkler S, Nowicki B, Dollé F, Farde L. Mol Imaging Biol; 2004 Jul 15; 6(1):17-26. PubMed ID: 15018825 [Abstract] [Full Text] [Related]
14. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. Farde L, Ito H, Swahn CG, Pike VW, Halldin C. J Nucl Med; 1998 Nov 15; 39(11):1965-71. PubMed ID: 9829590 [Abstract] [Full Text] [Related]
15. PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole. Tipre DN, Zoghbi SS, Liow JS, Green MV, Seidel J, Ichise M, Innis RB, Pike VW. J Nucl Med; 2006 Feb 15; 47(2):345-53. PubMed ID: 16455642 [Abstract] [Full Text] [Related]
18. Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain. Hume SP, Ashworth S, Opacka-Juffry J, Ahier RG, Lammertsma AA, Pike VW, Cliffe IA, Fletcher A, White AC. Eur J Pharmacol; 1994 Dec 27; 271(2-3):515-23. PubMed ID: 7705452 [Abstract] [Full Text] [Related]
19. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635. Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Weissfeld L, Mathis CA, Drevets WC, Wagner A, Hoge J, Ziolko SK, McConaha CW, Kaye WH. Arch Gen Psychiatry; 2005 Sep 27; 62(9):1032-41. PubMed ID: 16143735 [Abstract] [Full Text] [Related]
20. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors. Hillmer AT, Wooten DW, Bajwa AK, Higgins AT, Lao PJ, Betthauser TJ, Barnhart TE, Rowley HA, Stone CK, Johnson SC, Mukherjee J, Christian BT. J Nucl Med; 2014 Dec 27; 55(12):1973-9. PubMed ID: 25453045 [Abstract] [Full Text] [Related] Page: [Next] [New Search]